$1.31
-0.06-4.38%
At close: Jun 9, 5:00 PM EST
$1.32
0.00910.69%
After Hours: 6:51 PM EST
Traws Pharma Inc Earnings Estimates
TRAWNASDAQ
Traws Pharma Earnings Estimates, EPS & Revenue | NASDAQ:TRAW
Traws Pharma (TRAW) is scheduled to report Q2 earnings on August 13, 2026. Analysts estimate EPS of $-1.04 and quarterly revenue of N/A.
In the most recent quarter (Q1), Traws Pharma reported EPS of $-0.53, beating estimates of $-0.56 by 0.05%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Traws Pharma has averaged an EPS surprise of 0.23% and a revenue surprise of 0.06%.
Earnings Date
Aug 13
EPS Estimate
$-1.040
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2.73M
Traws Pharma Earnings History
Analyze the earnings history of Traws Pharma using advanced sorting and filters.
Loading calendar...
Traws Pharma (TRAW) Earnings Per Share
The chart below shows Traws Pharma's reported EPS compared to analyst estimates over recent quarters.
Traws Pharma (TRAW) Revenue
The chart below shows Traws Pharma's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Traws Pharma (NASDAQ:TRAW) reporting earnings?
Traws Pharma (TRAW) is scheduled to report earnings on August 13, 2026. The last reported earnings were for reported on May 15, 2026 for Q1.
What were the latest earnings per share (EPS) for Traws Pharma (NASDAQ:TRAW)?
The Actual EPS was $-0.53, which beat the estimate of $-0.56.
What were Traws Pharma’s (NASDAQ:TRAW) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
